(Updated - September 2, 2025 6:04 AM EDT)

Oppenheimer analyst Jeff Jones initiates coverage on Pelthos Therapeutics (NYSE: PTHS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE